Biotech's Comeback Kid - Forbes | Life Sciences, Pharma and Biotech News | Scoop.it
After languishing in the shadow of Genentech for years, Biogen, with a new CEO, a promising new drug and a soaring share price, could be the next big thing in the drug business.